Debt to Equity Ratio: A measure of a company's financial leverage calculated by dividing its long-term debt by shareholders equity. Calculated as: Total Debt / Shareholders Equity
Yew Bio-Pharm Group Inc. (YEWB) had Debt to Equity Ratio of 0.21 for the most recently reported fiscal quarter, ending 2021-09-30.
| Income Statement Financials | |
$0.11M |
|
$-1.55M |
|
$0.95M |
|
$-0.84M |
|
$1.67M |
|
$-1.56M |
|
$-0.00M |
|
$-1.56M |
|
$-1.56M |
|
$-1.56M |
|
$-1.56M |
|
$-1.56M |
|
$-1.56M |
|
$-1.56M |
|
$-0.89M |
|
51.70M |
|
51.70M |
|
$-0.03 |
|
$-0.03 |
|
| Balance Sheet Financials | |
$13.93M |
|
$0.53M |
|
$47.46M |
|
$61.40M |
|
$12.54M |
|
-- |
|
$2.05M |
|
$14.60M |
|
$46.80M |
|
$1.06M |
|
$46.80M |
|
51.70M |
|
| Cash Flow Statement Financials | |
$6.93M |
|
$-7.36M |
|
$0.08M |
|
$0.56M |
|
$0.03M |
|
$-0.54M |
|
-- |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.11 |
|
-- |
|
-- |
|
-- |
|
|
Debt to Equity Ratio |
0.21 |
-762.96% |
|
-1415.24% |
|
-1415.24% |
|
-- |
|
-1415.63% |
|
-1408.14% |
|
$11.51M |
|
-- |
|
-- |
|
-- |
|
0.00 |
|
7.72 |
|
0.01 |
|
0.01M |
|
-3.33% |
|
-146.86% |
|
-2.54% |
|
-3.33% |
|
$0.91 |
|
$0.22 |
|
$0.13 |
|